GenePOC to attend annual meeting of AMP in Charlotte, North Carolina, Nov. 10 to 12, 2016

GenePOC will attend the Association for Molecular Pathology’s (AMP) annual meeting, November 10-12, 2016 to be held at the Charlotte Convention Center, Charlotte – North Carolina.

As the leading event for Molecular Pathology and Molecular Diagnostics, it is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world.

GenePOC will be in Booth #1908. Come and join us – we will be pleased to meet you !

Read more about AMP 2016 here

Debiopharm invests double digit millions in GenePOC

Debiopharm invests double-digit millions in  GenePOC, specialized in the development of rapid diagnostic tests. GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production line in Martigny. Click here for the details.

GenePOC to attend the AACC Annual Meeting in Philadelphia, July 31- August 4, 2016.

GenePOC will attend the 68th AACC Annual Scientific Meeting & Clinical Lab Expo, July 31-August 4, 2016 to be held at the Pennsylvania Convention Center.

As the leading event for laboratory medicine worldwide, the 68th AACC Annual Scientific Meeting & Clinical Lab Expo is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world.

GenePOC will be in Booth #4270.

Come and join us, we will be pleased to meet you !

Read more about AACC 2016

 

GenePOC to attend Next Generation Dx Summit in Washington, August 23-26 2016.

GenePOC will attend the 8th Next Generation Dx Summit to be held at the Grand Hyatt in Washington, D.C. from August 23 to 26, 2016.

This event brings together more than 1,000 diagnostic professionals from around the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.

GenePOC’s CEO, Patrice Allibert, will give a presentation on Tuesday, August 23, during the session “Enabling Point of Care Diagnostics”. Click here to read the full abstract.

GenePOC will also be in Booth #1908.

Come and join us, we will be pleased to meet  you !

Read more about Next Generation Dx Summit 2016.

 

GenePOC proud to announce $5.7 million GAPP partnership to support development and commercialization of two new tests on its POC platform

GenePOC Inc., a Canadian company developing cost-effective and rapid molecular devices to detect pathogen genes at Point-of-Care, is pleased to announce that its project, in partnership with Université Laval, was successful in securing funding from Genome Canada and Génome Québec through the Genomic Applications Partnership Program (GAPP).

The project, entitled “New test to rapidly diagnose infections”, aims to support the development and commercialization of two new tests for the rapid diagnostic of infections. The GAPP program partners academic researchers with “users” of genomics to support projects that address real world challenges and opportunities.

“This funding from the Canadian government provides an opportunity for GenePOC to leverage the broad genomic expertise from the labs of Dr Michel G. Bergeron” said Patrice Allibert, PhD, CEO GenePOC. “ The first two assays developed by GenePOC, namely Group B Strep (GBS) and Clostridium Difficile (C.diff.), are scheduled to enter clinical trials validation within the next weeks. This project will help accelerate the development of our assay menu and will increase the attractiveness of our offer.”

Click here to read the detailed press release and background information from Genome Canada.

Click here to read the press release from Génome Québec